HUMAN BABESIOSIS IN EUROPE

被引：22

作者：

BRASSEUR, P ^{[1
]}

GORENFLOT, A ^{[1
]}

机构：

[1] UFR SCI PHARMARCEUT & BIOL,BIOL CELLULAIRE LAB,F-34060 MONTPELLIER,FRANCE

来源：

MEMORIAS DO INSTITUTO OSWALDO CRUZ | 1992年 / 87卷

关键词：

HUMAN BABESIOSIS; BABESIA-DIVERGENS; EPIDEMIOLOGY; TREATMENT;

D O I：

10.1590/S0074-02761992000700019

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 mum) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varyed from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycine (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention.

引用

页码：131 / 132

页数：2